Patents by Inventor Luqing Yang

Luqing Yang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190330201
    Abstract: The disclosure discloses an aryl hydrocarbon receptor modulators of formula (I), and pharmaceutically acceptable salts, R? is H, CN, CH2(OH)R0, CmH2m+1, CnH2n-1, CnH2n-3, two Ra is independently H, or two Ra together form ?O or ?N—W3—R1; A is a C6 to C10 aromatic ring, or a C2 to C10 heteroaromatic ring containing 1 to 5 heteroatom from N, O and S, or 4 to 7 membered non-aromatic heterocyclic ring containing 1 to 3 heteroatom from N, O and S and C?N, which are with no substituent or substituted by 1 or 3 R; Q is R, or a C6 to C10 aromatic ring or a C2 to C10 heteroaromatic ring containing 1 to 5 heteroatom selected from N, O and S, which are with no substituent or substituted by 1 or 3 R; R is Rc connected with C or RN connected with N.
    Type: Application
    Filed: December 22, 2017
    Publication date: October 31, 2019
    Inventors: Luqing YANG, Guodong LI, Suoming ZHANG
  • Publication number: 20190307731
    Abstract: Disclosed is an aryl hydrocarbon receptor modulator of formula (I), and a pharmaceutically acceptable salt thereof, wherein R? is H, CN, CH2(OH)R0, CmH2m+1, CnH2n-1, CnH2n-3, two Ra are independently H or two Ra together form ?O or ?N—W3—R1; A is a C6 to C10 aromatic ring unsubstituted or substituted with 1 to 3 R, or a C2-C10 heteroaromatic ring interrupted by 1 to 5 heteroatoms selected from N, O, and S or a 4 to 7 membered nonaromatic heterocyclic ring containing C?N and interrupted by 1 to 3 heteroatoms selected from N, O, and S, with either one unsubstituted or substituted with 1 to 3 R; Q is R, or is a C6 to C10 aromatic ring or a C2 to C10 heteroaromatic ring unsubstituted or substituted with 1 to 3 R and interrupted by 1 to 5 heteroatoms selected from N, O, and S; and R is Rc which is C-attached or RN which is N-attached.
    Type: Application
    Filed: December 21, 2018
    Publication date: October 10, 2019
    Applicant: Ariagen, Inc.
    Inventors: Luqing YANG, Guodong LI, Suoming ZHANG
  • Publication number: 20190284149
    Abstract: Disclosed is an aryl hydrocarbon receptor modulator of formula (I), and a pharmaceutically acceptable salt thereof, wherein R? is H, CN, CH2(OH)R0, CmH2m+1, CnH2n?1, CnH2n?3, two Ra are independently H or two Ra together form =0 or ?N—W3—R1; A is a C6 to C10 aromatic ring unsubstituted or substituted with 1 to 3 R, or a C2-C10 heteroaromatic ring interrupted by 1 to 5 heteroatoms selected from N, 0, and S or a 4 to 7 membered nonaromatic heterocyclic ring containing C?N and interrupted by 1 to 3 heteroatoms selected from N, 0, and S, with either one unsubstituted or substituted with 1 to 3 R; Q is R, or is a C6 to C10 aromatic ring or a C2 to C10 heteroaromatic ring unsubstituted or substituted with 1 to 3 R and interrupted by 1 to 5 heteroatoms selected from N, 0, and S; and R is RC which is C-attached or RN which is N-attached.
    Type: Application
    Filed: December 21, 2018
    Publication date: September 19, 2019
    Applicant: ARIAGEN, INC.
    Inventors: Jiasheng Song, Suoming Zhang, Guodong Li, Luqing Yang
  • Publication number: 20190084948
    Abstract: Methods of synthesizing 2?(1?H-indole-3?-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE) and structural analogs thereof. The methods include condensation reactions or condensation and oxidation reactions to form the thiazoline or thiazole moiety of ITE or its structural analogs.
    Type: Application
    Filed: August 16, 2018
    Publication date: March 21, 2019
    Applicant: Ariagen, Inc.
    Inventors: Jiasheng Song, Suoming Zhang, Guodong Li, Luqing Yang
  • Publication number: 20170291881
    Abstract: Methods of synthesizing 2-(1?H-indole-3?-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE) and structural analogs thereof. The methods include condensation reactions or condensation and oxidation reactions to form the thiazoline or thiazole moiety of ITE or its structural analogs.
    Type: Application
    Filed: September 10, 2015
    Publication date: October 12, 2017
    Applicant: AhR Pharmaceuticals, Inc.
    Inventors: Jiasheng Song, Suoming Zhang, Guodong Li, Luqing Yang